IGM Biosciences is a leading biotechnology company that is revolutionizing the field of antibody medicines. They are focused on developing a new class of therapeutic antibodies for the treatment of cancer, autoimmune and inflammatory diseases, and infectious diseases. What sets IGM apart is their innovative approach of utilizing the naturally occurring IgM antibody structure to create super antibodies that have greater binding power and the potential to generate novel therapeutic options for patients.

With the world's most advanced research and development program for engineered therapeutic IgM antibodies, IGM is exploring scientific boundaries and opening up new approaches to disease treatment. Their platform aims to expand and improve the inherent qualities of IgM antibodies, allowing them to produce a range of therapeutic antibodies at scale. If you are passionate about making an impact in the field of antibody medicines, IGM Biosciences provides an exciting opportunity to be part of their team.

Join them in bringing a new class of antibody medicines to patients and revolutionizing the way diseases are treated